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CC BY-NC-ND license (http://creativeBackground: Hepatitis B virus (HBV) infection is strictly species and tissue specific, therefore
none of the cell models established previously can reproduce the natural infection process
of HBV in vitro. The aim of this study was to establish a new cell line that is susceptible to
HBV and can support the replication of HBV.
Methods: A hybrid cell line was established by fusing primary human hepatocytes with HepG2
cells. The hybrid cells were incubated with HBV-positive serum for 12 hours. HBV DNA was de-
tected by quantitative fluorescence polymerase chain reaction (QF-PCR). HBsAg (surface anti-
g en ) and HBeAg ( e x t r a c e l l u l a r f o rm o f co r e an t i g en ) we r e ob s e r v ed by
electrochemiluminescence (ECL). HBcAg (core antigen) was detected by the indirect immuno-
fluorescence technique. HBV covalently closed circular DNA (cccDNA) was analyzed by South-
ern blot hybridization and quantified using real-time PCR.
Results: A new cell line was established and named HepCHLine-7. The extracellular HBV DNA
was observed from Day 2 and the levels ranged from 9.80 ( 0.32)  102 copies/mL to 3.12
( 0.03)  104 copies/mL. Intracellular HBV DNA was detected at Day 2 after infection andt of Infectious Diseases, Qilu Hospital, Shandong University, Wenhua Xi Road 107, Ji’nan 250012,
il.com (L.-X. Ma).
.08.008
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472 L.-T. Sai et al.the levels ranged from 7.92 ( 1.08)  103 copies/mL to 5.63 ( 0.11)  105 copies/mL. HBsAg
in the culture medium was detected from Day 4 to Day 20. HBeAg secretion was positive from
Day 5 to Day 20. HBcAg constantly showed positive signals in approximately 20% ( 0.82%) of
hybrid cells. Intracellular HBV cccDNA could be detected as early as 2 days postinfection and
the highest level was 15.76 ( 0.26) copies/cell.
Conclusion: HepCHLine-7 cells were susceptible to HBV and supported the replication of HBV.
They are therefore suitable for studying the complete life cycle of HBV.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).Introduction
Hepatitis B virus (HBV) is a member of the hepadnaviridae
family that poses a significant health threat to millions of
people worldwide. It has been estimated that two billion
people have serologic evidence of past or present HBV
infection and 360 million people suffer from chronic HBV
infection.1,2 People infected with HBV have a much higher
risk of developing liver diseases, such as cirrhosis, liver
failure, and hepatocellular carcinoma.3,4
HBV has a small, circular, partial double-stranded DNA
genome of 3200 bases. The life cycle of HBV is believed to
begin when the virus attaches to the host cell membrane.
Then the viral membrane fuses with the cell membrane and
the viral genome is released into the cell.5,6 After the viral
genome has entered the host cell, the partially double-
stranded DNA converts into covalently closed circular DNA
(cccDNA). The cccDNA acts as the template for further
propagation of pregenomic RNA and mRNA.7
HBV infection is characterized by a narrow species and
tissue tropism. Therefore, a reliable and sensitive in vitro
infection cell model is still lacking. Currently, there are two
main cell models used for the study of HBV in vitro,
hepatoma-derived cells and primary human hepatocytes.
The hepatoma-derived cells, such as HepG2, Huh-6, and
Huh-7 cells, have been confirmed to support HBV tran-
scription and replication. However, in these processes of
infection, the integrated and transfected HBV genome acts
as the template or the cells are added to chemical reagents
to improve their susceptibility.8e11 This processing destroys
the complete life cycle of HBV. Although primary human
hepatocytes are susceptible to HBV,12,13 limited resources
and technical difficulties associated with culture in vitro
restrict their use as a model for HBV infection.
In this study, we attempted to establish an in vitro
infection cell culture system by fusing primary human he-
patocytes with HepG2 cells, which could support the nat-
ural infection of HBV.Methods
Isolation and culture of primary human hepatocytes
Liver tissue was obtained from the surgical removal of liver
tissue of a female patient with hepatic hemangioma who
had no serological evidence of past or present HBVinfection. This study was approved by the Medical Ethics
Committee of the Shandong University Medical School,
Ji’nan, China.
Hepatocytes were isolated using a two-step collagenase
perfusion technique as previously reported.14,15 The iso-
lated hepatocytes were resuspended in hepatocyte medium
containing Dulbecco’s modified Eagle’s medium (DMEM,
Gibco, Carlsbad, CA, USA), supplemented with 200 mL/L
(20%) fetal bovine serum (FBS, Gibco, Carlsbad, CA, USA),
20 mg/L dimethyl sulfoxide (DMSO, Roche, Basel,
Switzerland), 20 mg/L polyethylene glygol (PEG, Roche,
Basel, Switzerland), 10 mg/L insulin, 0.1 mmol/L dexa-
methasone, and 4 mmol/L glutathione. The cells were
cultured in an incubator at 37C in a humidified atmosphere
with 5% CO2 in air. The viability of hepatocytes was deter-
mined by trypan blue (Gibco, Carlsbad, CA, USA) dye
exclusion.
Obtainment of HGPRT(L) HepG2 cells
The original HepG2 cells were supplied by the China Centre
for Type Culture Collection (Wuhan, China). Hypoxanthine-
guanine phosphoribosyltransferase null [HGPRT()] HepG2
cells were selected from the original HepG2 cells in the
present of ethyl methane sulfonate (EMS, Sigma Aldrich, St
Louis, MO, USA) and 6-mercaptopurine (6-MP, Sigma
Aldrich, St Louis, MO, USA). The cells were resistant to
0.3 g/L EMS and 10 mg/L 6-MP but could not grow in
hypoxanthineeaminopterinethymidine (HAT, Gibco, Carls-
bad, CA, USA) medium (DMEM supplemented with 5% FBS,
100 mmol/L hypoxanthine, 0.4 mmol/L aminopterin, and
16 mmol/L thymidine), which suggested a complete defect
in inosinic acid pyrophosphorylase (IPP).16 In addition,
reversion to 6-MP was not detected. The characteristics of
HGPRT() HepG2 cells were similar to those of the original
HepG2 cells, such as morphology and the mean chromo-
some number.
Cell fusion and selection of the hybrid cells
Hepatocytes (1  106 cells) and HGPRT() HepG2 cells
(2  106 cells) were mixed in a tube in the present of 50%
PEG 1500 and stirred gently. Then, the mixed cells were
washed twice with DMEM. The final mixture was plated into
a 96-well plate in HAT medium. The medium was changed
every 2e3 days for 2 weeks. When the cells could stably
grow, they were diluted into 10 cells/well, two cells/well,
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tion method. After several rounds of limiting dilution
cloning, one hybrid cell clone was obtained and named
HepCHLine-7. Thereafter, the culture medium was changed
to HT medium for 1 week. Then, the obtained hybrid cells
were maintained in DMEM supplemented with 5% FBS.
Analysis of the chromosomes in hybrid cells
Chromosome numbers were counted in original HepG2,
HGPRT() HepG2, and HepCHLine-7 cells by the trypsin G-
banding method as described previously.17 Twenty cells of
each group were analyzed.
Infection with HBV in vitro
Serum containing HBV DNA 7.5  108 copies/mL was ob-
tained from a chronic hepatitis B patient who was positive
for HBsAg (surface antigen) and HBeAg (extracellular form
of core antigen). About 3  106 hybrid cells were incubated
with 4 mL DMEM supplemented with 10% HBV serum in a
water bath for 12 hours at 37C with gentle shaking. The
ratio of cell and HBV DNA copy was 1:100. HGPRT() HepG2
cells were used as a control. Following 12 hours of expo-
sure, the cells were washed five times with phosphate-
buffered saline (PBS) to remove the unabsorbed virus, and
the PBS used in the fifth wash was collected for detection of
the presence of HBV DNA. Then, the infected cells were
cultured in DMEM supplemented with 10% FBS. The start of
this incubation was taken as time zero.
Detection of HBV DNA in cells and culture medium
Postinfection, the infected cells were harvested and their
culture supernatants were collected in order every day. All
samples were stored at 70C until used. To avoid potential
interference from the residue of the infectious source, the
detection of HBV DNA was performed from the 2nd day after
infection. Total DNA was extracted from infected cells and
culture medium according to the method described previ-
ously.18 The HBV DNA was detected by quantitative fluo-
rescence polymerase chain reaction (QF-PCR). HBV PCR
Fluorescent Quantitative Detection Kit (Piji Biotec, Shenz-
hen, China) was used according to the manufacturer’s
instructions.
HBV-infected HGPRT() HepG2 cells and uninfected
HepCHLine-7 cells were used as a control.
Detection of HBsAg, HBeAg, and HBcAg
The HBsAg and HBeAg levels in the culture medium were
measured from the 2nd day postinfection by electro-
chemiluminescence (ECL) using an Elecsys 2010 fully-
automated ECL analyzer (Roche, Basel, Switzerland).
The HBcAg (core antigen) within the infected cells was
observed by indirect immunofluorescence analysis. First,
infected cells were fixed with 4% paraformaldehyde for 20
minutes at 4C and permeabilized in Triton X-100. Then,
cells were blocked by incubation with PBS containing 10%
goat serum for 30 minutes at 37C. Cells were then incu-
bated with a specific mouse monoclonal antibody againstHBcAg at 4C overnight. Thereafter, cells were incubated
with the secondary antibody, a fluorescein isothiocyanate
(FITC)-tagged goat antimouse immunoglobulin G (IgG), for
30 minutes at 37C. Finally, cells were incubated in 40,6-
diamidino-2-phenylindole (DAPI) for 10 minutes at room
temperature and examined using an inverted fluorescence
microscope (Olympus, Tokyo, Japan).
HBV-infected HGPRT() HepG2 cells and uninfected
HepCHLine-7 cells were used as a control.Detection of HBV cccDNA
The cells were washed with PBS and lysed in lysis buffer
(50mM Tris, 100mM NaCl, 0.1% Triton X-100, 5mM MgCl2, pH
8.0) for 10 minutes at 4C. Nuclei were separated from the
cytoplasmic fraction by centrifugation at 270 g for 2 mi-
nutes at 4C. Episomal DNA was extracted from nuclei as
previously described.19 Cells were lysed in lysis buffer
without pronase, and proteinedetergent complexes were
precipitated by the addition of 0.25 mL of 2.5M KCl. The
lysates were mixed by shaking and centrifuged to remove
most of the cellular DNA. Viral cccDNA in the supernatant
was extracted with an equal volume of phenol. HBV
cccDNA was further purified using the method of Yang
et al.20 The purified HBV cccDNA were detected by
Southern blot hybridization and quantified using real-time
PCR as described previously.21 The DIG High Prime DNA
Labeling and Detection Starter Kit I (Roche, Basel,
Switzerland) was used.
HBV-infected HGPRT() HepG2 cells and uninfected
HepCHLine-7 cells were used as a control.Blocking test
The viral serum from a hepatitis B patient was pre-
incubated with various antibodies against the pre-S1, pre-
S2, and S domains of HBV surface proteins in a water bath
for 30 minutes at 37C. Then, approximately 3  106 hybrid
cells were infected by the treated viral serum in a water
bath for 12 hours at 37C with gentle shaking. The ratio of
cell and HBV DNA copy was 1:100. HBV DNA, HBsAg, HBeAg,
HBcAg, and cccDNA were detected from Day 2 to Day 18
postinfection.Results
Establishment of hybrid cell line
A cell line named HepCHLine-7 was established from one
colony. The morphology did not change after the 30th sub-
culture. To confirm that the HepCHLine-7 cell line was a
hybrid line, its chromosome number was analyzed by the G-
banding method. The mean modal chromosome numbers
were 51, 53, and 99 in original HepG2, HGPRT() HepG2,
and HepCHLine-7 cells. The results indicated that the
HepCHLine-7 was a hybrid cell line by fusing HGPRT()
HepG2 cells (53 chromosomes) with human hepatocytes (46
chromosomes).
AB
Figure 2. Detection of HBsAg and HBeAg in culture medium.
(A) HBsAg was detected from Day 4 to Day 18 postinfection.
The levels ranged from 1.670 ( 0.031) IU/mL to 92.450
( 0.735) IU/mL. (B) HBeAg was observed from Day 5 to Day 18
postinfection. The levels ranged from 1.001 (0.002) s/co to
2.103 (0.007) s/co. HBsAg Z surface antigen of hepatitis B
virus; HBeAg Z extracellular form of the core antigen of
hepatitis B virus; s/co Z absorbance rate/cut-off ration.
A
B
Figure 1. Detection of HBV DNA within cells and in culture
medium. (A) HBV DNA was extracted from infected cells and
observed from Day 2 to Day 18 postinfection. The levels ranged
from 7.92 ( 1.08)  103 copies/mL to 5.63
( 0.11)  105 copies/mL. (B) HBV DNA was isolated from
culture medium and detected from Day 2 to Day 18 post-
infection. The levels ranged from 9.80 ( 0.32)  102 copies/
mL to 3.12 ( 0.03)  104 copies/mL. HBVZ hepatitis B virus.
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The total DNA was extracted from infected cells and
quantified by QF-PCR. The levels of intracellular HBV DNA
ranged from 7.92 ( 1.08)  103 copies/mL to 5.63
( 0.11)  105 copies/mL and the highest level appeared at
Day 10 (Fig. 1A). To investigate whether HBV DNA could be
released into culture medium, viral DNA was extracted
from the medium and quantified. The copy number of viral
load ranged from 9.80 ( 0.32)  102 copies/mL to 3.12
( 0.03)  104 copies/mL with a secretion peak at Day 12
(Fig. 1B). These HBV DNA molecules were not detected in
the culture medium at time zero and in the fifth washing
with PBS. HBV DNA was not observed in the controlled cells.
Detection of HBsAg, HBeAg, and HBcAg
To investigate whether infected cells could secrete HBV-
specific antigen into the culture medium, the culture me-
dium was collected and detected for the presence of HBsAg
and HBeAg by ECL analysis. HBsAg was observed from Day 4
postinfection and the levels ranged from 1.670 ( 0.031)
IU/mL to 92.450 ( 0.735) IU/mL ( 1.0 IU/mL was
considered positive; Fig. 2A). HBeAg was detected from Day
5 postinfection and the levels ranged from 1.001 ( 0.002)
s/co to 2.103 ( 0.007) s/co (absorbance rate/cut-off
ration, 1.0 s/co was considered positive; Fig. 2B). HBsAg
and HBeAg were not detected in the culture medium of
controlled cells.To estimate the percentage of infection cells, indirect
immunofluorescence was used to detect the presence of
HBcAg within the infected cells. HBcAg expression was first
observed at Day 4 after infection and constantly showed
positive signals in approximately 20% ( 0.82%) of hybrid
cells. However HBcAg did not appear positive within
controlled cells (Fig. 3).
Detection of HBV cccDNA
HBV cccDNA was detected by Southern blot hybridization. A
slight band of 2.0 kb was observed that corresponded to the
expected position for the HBV cccDNA. However, no cccDNA
was detected in controlled cells (Fig. 4). The formation of
HBV cccDNA was detected from Day 2 postinfection. By
quantification using real-time PCR, the copy number ranged
from 0.02 ( 0.002) copies/cell to 15.76 ( 0.26) copies/
cell.
Detection of the results of the blocking test
HBV DNA, HBsAg, HBeAg, HBcAg, and cccDNA were not
detected as they were in the control infection.
Discussion
Primary human hepatocytes and human fetal hepatocytes
have been reported to be susceptible to HBV infection.12,13
Figure 3. HBcAg was analyzed by indirect immunofluores-
cence. HBcAg was detected in (A) HBV-infected HepCHLine-7
cells, but was not found in (B) HBV-infected HGPRT() HepG2
cells and (C) uninfected HepCHLine-7 cells. HBcAg Z core
antigen of hepatitis B virus; HBV Z hepatitis B virus;
HGPRT Z hypoxanthine-guanine phosphoribosyltransferase.
Figure 4. Southern blot analysis of HBV cccDNA. Lanes: 1,
wholeHBVDNAprobe; 2, HBV-infectedHGPRT() HepG2 cells; 3,
Day 2 postinfection; 4, Day 10 postinfection; 5, Day 16 post-
infection; 6, uninfectedHepCHLine-7 cells. cccDNAZ covalently
closed circular DNA; HBV Z hepatitis B virus; HGPRT Z hypo-
xanthine-guanine phosphoribosyltransferase.
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sources and technical difficulties in culture. Hepatoma-
derived cell lines such as HepG2 cells were used for the
in vitro study of HBV and were confirmed to support the
replication of HBV. However, the viral genome was intro-
duced by integration or transfection rather than infec-
tion.8,9 In some previous studies, to improve theirsusceptibility, cells were subjected to treatment with DMSO
or PEG.10,11 However, these chemicals may induce an arti-
ficial mechanism for viral entry. The lack of efficient
virusecell interactions may be the major reason for HBV
insusceptibility. Therefore, these cell lines could reveal
some important details of HBV replication, but they were
not suitable for studying the early steps of the HBV life
cycle, such as attachment and penetration.
In this study, a new cell line named HepCHLine-7 was
established by fusing primary human hepatocytes with
HGPRT() HepG2 cells. To confirm that HepCHLine-7 cells
were hybrid cells, the trypsin G-banding method was used
to count the mean chromosome numbers. The results
showed that the modal chromosome numbers in
HepCHLine-7 cells, HGPRT() HepG2 cells, and primary
human hepatocytes were 99, 53, and 46, respectively.
Therefore, HepCHLine-7 cells were considered hybrid cells
containing genomes from the parental cells.
Initial evaluation of the infection system was carried out
using QF-PCR to detect HBV DNA. HBV DNA could be
observed both within cells and in the culture medium, and
the levels increased with the culture time. HBV DNA was
not detected in controlled cells and the fifth washing PBS,
which suggested that these DNA molecules were not from
the infectious source.
In addition to assay of HBV DNA, secretory HBV antigens
were detected in the culture medium and HBcAg was
detected throughout the cytoplasm. The synthesis of HBV-
specific antigens provided indication that replication and
expression of the HBV genome occurred in infected
HepCHLine-7 cells, whereas no significant replication or
476 L.-T. Sai et al.expression of the HBV genome was detected in controlled
cells. However, only about 20% ( 0.82%) of the cells
constantly expressed HBcAg on Day 4 after HBV infection,
which may be associated with the viral load and virulence.
In the early step of infection, the cells were infected and
supported the replication and expression of HBV when a
sufficient number of virus particles adhered to the surface
of the cells.
HBV cccDNA is a critical intracellular replicative inter-
mediate that acts as the template for transcription of viral
pregenome RNA and mRNA.7 Therefore, cccDNA is consid-
ered as the resource of new HBV DNA. In order to provide
further evidence that HepCHLine-7 cells can support the
replication of HBV, we detected the intracellular HBV
cccDNA. In the present study, HBV cccDNA was observed as
early as Day 2 postinfection. This phenomenon is consistent
with the view that the formation of cccDNA is a prerequisite
for entering the replication cycle of HBV and is considered
to be the earliest marker of HBV infection.
To determine whether the infection was blocked by
specific antibodies, the virus was pre-incubated with
various antibodies against the pre-S1, pre-S2, and S do-
mains of HBV surface proteins. The infection was prevented
because HBV DNA and specific antigens were not detected
in the culture medium as they were in the control infection
(data not shown). The results indicated that the uptake of
HBV by HepCHLine-7 cells required specific attachment
sites on the surface of HBV.
In conclusion, detection of HBV viral load, specific an-
tigens, and cccDNA levels provided direct evidence that the
HepCHLine-7 cell line was susceptible to HBV and supported
the replication of HBV in a natural way. The HepCHLine-7
cell line inherited the high susceptibility to HBV from
human hepatocytes and immortality from HepG2 cell. This
in vitro infection system will be a useful tool to study the
complete process of HBV infection and test the efficacy of
antiviral drugs.
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